Natus to be Exclusive U.S. Agent for the First Neonatal MRI Device

  • Embrace™ Neonatal MRI system is the First U.S. FDA approved MRI Designed for Neonatal Brain and Head Imaging in Neonatal Intensive Care Units (NICU)

PLEASANTON, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it will be Aspect Imaging, Ltd.’s exclusive selling agent for the Embrace™ Neonatal MRI system in the United States.  The Embrace™ Neonatal MRI System is designed specifically for imaging of the neonatal head. The Embrace™ Neonatal MRI System may be used on neonates with a head circumference up to 38 centimeters and weight between 1 and 4.5 kilograms. The system has a temperature-controlled incubator placed directly into the MRI system, minimizing movement of the baby. If urgent access to the baby is necessary during the imaging process, the baby can typically be removed from the system in less than 30 seconds.

The Embrace™ Neonatal MRI System can be placed inside a NICU environment because the system does not require a safety zone or a radiofrequency shielded room. Since the system is fully enclosed, medical device implants or any device in the NICU in close proximity to the system are not required to be “MR Conditional” or “MR Safe.”

"Natus is excited to partner with Aspect Imaging to bring this innovative MRI device to our NICU customers," said Jim Hawkins, President and Chief Executive Officer of Natus. "The Embrace™ MRI represents one of the most innovative products introduced into the NICU in the past several years as it significantly reduces risk associated with transporting fragile newborn babies."

In addition to its exclusive agency agreement, Natus will also gain equity participation in Aspect Imaging, Ltd.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.

Additional information about Natus Medical can be found at

About Aspect Imaging

Aspect Imaging, Ltd. is a world leader in the design and development of complete, compact MRI and NMR systems. Their unique technology platform is the backbone for a wide range of products, spanning preclinical, medical, oil and gas, and advanced industrial markets. Advanced industrial applications include rheological analysis of both food products and industrial drilling mud with Aspect Imaging’s FlowscanTM. The AI-60 NMR is used for real-time, continuous flow-through stream analysis of dense and opaque materials such as crude oil, HF, and silicon production. For more information, visit

Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President Finance and Chief Financial Officer
(925) 223-6700

Primary Logo

Source: Natus Medical Incorporated